The prescription drug Elmiron, used to treat interstitial cystitis, has recently been the subject of intense legal scrutiny. Numerous plaintiffs have filed lawsuits alleging that long-term use of Elmiron led to vision-related injuries, including a rare and potentially irreversible eye disorder. An Illinois lawyer can help you through your case to ensure you are taking the proper steps.
What the Elmiron Litigation is All About
In the ongoing litigation surrounding the prescription medication Elmiron, it has been revealed that the drug has led to pigmentary maculopathy, a rare and potentially irreversible eye disorder. Manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, Elmiron (pentosan polysulfate sodium) was approved by the FDA in 1996 to treat interstitial cystitis, a chronic bladder condition.